Jonzzon Soren, Suleiman Leena, Yousef Andrew, Young Brenda, Hart Janace, Peschl Patrick, Reindl Markus, Schaller Kristin L, Bennett Jeffrey L, Waubant Emmanuelle, Graves Jennifer S
Medical School of the University of California, San Francisco, CA, USA.
Department of Neurology, University of California, San Francisco, CA, USA.
J Child Neurol. 2020 Jan;35(1):77-83. doi: 10.1177/0883073819877334. Epub 2019 Sep 30.
Limited data exist on isolated optic neuritis in children. We report the clinical features and treatment of pediatric subjects with monophasic and recurrent idiopathic optic neuritis. This retrospective cohort study of patients with isolated optic neuritis identified 10 monophasic and 7 recurrent optic neuritis cases. Monophasic optic neuritis patients were older (mean 13.3 ± 4.22) than those with recurrent idiopathic optic neuritis (9.86 ± 3.63). Females represented 50% of monophasic and 85.7% of recurrent idiopathic optic neuritis cases. Patients with monophasic optic neuritis were less likely to have a bilateral onset than recurrent idiopathic optic neuritis (40% vs 57.1%). Only 1 case had oligoclonal bands in the cerebrospinal fluid CSF. Most recurrent idiopathic optic neuritis cases had evidence of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (5/7). Treatment of recurrent idiopathic optic neuritis cases included intravenous pulse glucocorticosteroids and immunotherapy. We observed differences between recurrent and monophasic idiopathic optic neuritis. Immunosuppression appeared to prevent further relapses in recurrent idiopathic optic neuritis patients. Weaning immunotherapies after several years of quiescence in recurrent idiopathic optic neuritis may be possible, but larger studies are needed.
关于儿童孤立性视神经炎的数据有限。我们报告单相性和复发性特发性视神经炎儿科患者的临床特征及治疗情况。这项对孤立性视神经炎患者的回顾性队列研究确定了10例单相性和7例复发性视神经炎病例。单相性视神经炎患者的年龄(平均13.3±4.22岁)大于复发性特发性视神经炎患者(9.86±3.63岁)。单相性视神经炎病例中女性占50%,复发性特发性视神经炎病例中女性占85.7%。单相性视神经炎患者双侧发病的可能性低于复发性特发性视神经炎患者(40%对57.1%)。仅1例患者脑脊液(CSF)中有寡克隆带。大多数复发性特发性视神经炎病例有抗髓鞘少突胶质细胞糖蛋白(MOG)抗体的证据(5/7)。复发性特发性视神经炎病例的治疗包括静脉注射脉冲糖皮质激素和免疫疗法。我们观察到复发性和单相性特发性视神经炎之间存在差异。免疫抑制似乎可预防复发性特发性视神经炎患者进一步复发。复发性特发性视神经炎患者在病情静止数年之后停用免疫疗法或许可行,但还需要更大规模的研究。